Eric Lefebvre, Chief Medical Officer at PLIANT THERAPEUTICS, INC. (PLRX), sold 20,590 shares at $17.23 ($355K) on 2024-01-17, disclosed to the SEC on 2024-01-19.
Scheduled sale ($355k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.23 | 10,295 | $177K | 50.0% |
| 2 | $17.23 | 10,295 | $177K | 50.0% |
| Total | $17.23 avg | 20,590 | $355K | 100% |
| Filing → |
| PLRX | SELL | 2023-07-19 | $804K | — | Filing → |
| PLRX | SELL | 2023-04-03 | $596K | — | Filing → |
| PLRX | SELL | 2023-01-25 | $2.3M | — | Filing → |